Cytek Biosciences Inc

CTKB

Company Profile

  • Business description

    Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

  • Contact

    47215 Lakeview Boulevard
    FremontCA94538
    USA

    T: +1 877 922-9835

    https://www.cytekbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    702

Stocks News & Analysis

stocks

SpaceX is scaling AI infrastructure on earth, data centers in space might be next

Our view on the first results as a publicly traded company.
stocks

Investors too optimistic about overvalued ASX share

Upgraded first-half revenue guidance at the upper end of the previously announced range.
stocks

Restructuring at big four bank

Job cuts create capacity to invest as revenue growth slows.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,917.1039.50-0.44%
CAC 407,822.2999.39-1.25%
DAX 4025,405.41239.63-0.93%
Dow JONES (US)52,856.09360.210.69%
FTSE 10010,710.8342.05-0.39%
HKSE22,934.68717.19-3.03%
NASDAQ26,702.86278.041.05%
Nikkei 22562,907.841,713.40-2.65%
NZX 50 Index13,746.8414.45-0.11%
S&P 5007,757.1744.600.58%
S&P/ASX 2008,793.2038.10-0.43%
SSE Composite Index3,658.0355.00-1.48%

Market Movers